Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the close of a ...

iACT Stealth is designed to work in tandem with Pluristyx's FailSafe (R) technology. FailSafe's drug-inducible safety feature acts as a genetic "kill switch," allowing for the selective removal of any ...

The FDA granted regenerative medicine advanced therapy designation to RTx-015 for the treatment of retinitis pigmentosa.

HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

iACT Stealth is designed to work in tandem with Pluristyx’s FailSafe® technology. FailSafe’s drug-inducible safety feature acts as a genetic “kill switch," allowing for the selective removal of any ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

A new metabolic mechanism describes how tumors disable “gatekeeper” cells to prevent immune response to cancer.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

ABU DHABI, 5th April, 2026 (WAM) -- Abu Dhabi Stem Cells Center (ADSCC) has announced a new scientific milestone in regenerative medicine with the development of an advanced technique to generate ...

Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in ...